Cargando…

Why should we need the gut microbiota to respond to cancer therapies?

Cyclophosphamide, one of the most efficient tumoricidal, antiangiogenic, and immunostimulatory drugs employed to date mediates part of its effects through intestinal bacteria, against which the host becomes immunized during treatment. Our recent work suggests that anti-commensal effector pT(H)17 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viaud, Sophie, Daillère, Romain, Yamazaki, Takahiro, Lepage, Patricia, Boneca, Ivo, Goldszmid, Romina, Trinchieri, Giorgio, Zitvogel, Laurence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006853/ https://www.ncbi.nlm.nih.gov/pubmed/24800167 http://dx.doi.org/10.4161/onci.27574

Ejemplares similares

Turning tolerogenic into immunogenic ileal cell death through ileal microbiota: the key to unlock the mystery of colon cancer immunoscore?
por: Roberti, Maria Paula, et al.
Publicado: (2020)

Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2014)

Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
por: Michaud, Mickaël, et al.
Publicado: (2012)

An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013)

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy
por: Aranda, Fernando, et al.
Publicado: (2014)

Trial watch: Immunostimulatory cytokines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2014)

Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects
por: Kepp, Oliver, et al.
Publicado: (2012)

Trial Watch: Toll-like receptor agonists in oncological indications
por: Aranda, Fernando, et al.
Publicado: (2014)

ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013)

Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?
por: Facciabene, Andrea, et al.
Publicado: (2012)

Why does a mitochondrion need its individual cristae to be functionally autonomous?
por: Liesa, Marc
Publicado: (2020)

Telomeres and sirtuins: at the end we meet again
por: Amano, Hisayuki, et al.
Publicado: (2019)

Microbiome: Should we diversify from diversity?
por: Johnson, Katerina V.-A., et al.
Publicado: (2016)

Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and -6 in cancer cells
por: Végran, Frédérique, et al.
Publicado: (2013)

Acute Ischemic Stroke in Children – Should We Thrombolyze?
por: Vinayan, K. P., et al.
Publicado: (2022)

Gut microbiota and colon cancer: the carbohydrate link
por: Belcheva, Antoaneta, et al.
Publicado: (2014)

Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective
por: Rostoker, Guy, et al.
Publicado: (2021)

Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
por: Todaro, Matilde, et al.
Publicado: (2013)

Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes
por: Dieli, Francesco, et al.
Publicado: (2013)

Brain changes after COVID-19 — how concerned should we be?
por: Kremer, Stéphane, et al.
Publicado: (2022)

What Is the Storage Effect, Why Should It Occur in Cancers, and How Can It Inform Cancer Therapy?
por: Miller, Anna K., et al.
Publicado: (2020)

The humidity inside leaves and why you should care: implications of unsaturation of leaf intercellular airspaces
por: Buckley, Thomas N., et al.
Publicado: (2019)

Should We Invest in Martian Brine Research to Reduce Mars Exploration Costs?
por: Martín-Torres, Javier, et al.
Publicado: (2017)

Why do we need male contraceptives?
por: Cheng, C Yan, et al.
Publicado: (2013)

Why We Should Bathe
Publicado: (1888)

Should I stay or should I go now? Why risk communication is the critical component in disaster risk reduction
por: Fakhruddin, Bapon, et al.
Publicado: (2020)

Antimicrobial Resistance Exchange Between Humans and Animals: Why We Need to Know More
por: Parkhill, Julian
Publicado: (2022)

Why should we continue to learn?
por: Golnik, Karl
Publicado: (2017)

Author Correction: Why rankings of biomedical image analysis competitions should be interpreted with care
por: Maier-Hein, Lena, et al.
Publicado: (2019)

TAP-1 indirectly regulates CD4(+) T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-γ production
por: Goldszmid, Romina S., et al.
Publicado: (2007)

Cytotoxic T lymphocytes: Sniping cancer stem cells
por: Hirohashi, Yoshihiko, et al.
Publicado: (2012)

Systemic cancer immunotherapy with Toll-like receptor 7 agonists: Timing is everything
por: Hotz, Christian, et al.
Publicado: (2012)

Chronic liver inflammation dominated by interferon-γ can prevent hepatocarcinogenesis
por: Schrader, Jörg, et al.
Publicado: (2012)

FOXO3: A master switch for regulating tolerance and immunity in dendritic cells
por: Watkins, Stephanie K., et al.
Publicado: (2012)

FIST, a sword and shield fusokine for cancer immunotherapy
por: Penafuerte, Claudia, et al.
Publicado: (2012)

Host CD73 impairs anti-tumor immunity
por: Salmi, Marko, et al.
Publicado: (2012)

Cancer immunotherapy: Benefit and harm?
por: Characiejus, Dainius
Publicado: (2012)

IL-33/ST2 axis in innate and acquired immunity to tumors
por: Jovanovic, Ivan P., et al.
Publicado: (2012)

Immunotherapy: Is it different for sarcomas?
por: Cleton-Jansen, Anne-Marie, et al.
Publicado: (2012)

What is the influence of vaccination’s routes on the regression of tumors located at mucosal sites?
por: Nardelli-Haefliger, Denise, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lg841lkm2st6hl53vbjceskocl